FIRSTQUARTER2018 RESULTSPRESENTATION

Similar documents
1Q Fornebu, April 29, 2015 Luis Araujo and Svein Stoknes

Brisa Concessão Rodoviária. 1Q 2017 Traffic Update

Acquisition of Novartis Influenza Vaccines Business. 27 th October 2014

Investor Presentation

Third-quarter results 2013

PRESENTATION ON 2017 THIRD QUARTERLY RESULTS

Q4 Report Webcast February 7, 2019 Presenters: Renée Aguiar-Lucander, CEO Fredrik Johansson, CFO

M e d i a s e t G r o u p

For personal use only

Presentation of. Burgdorf, 1 st November 2012

For personal use only

Coloplast A/S. Investor presentation 1H 2005/06

Value creation through profitable growth Handelsbanken Nordic Large Cap Seminar, Stockholm 2016 Anders Lonning-Skovgaard, CFO

Straumann s net revenues reach CHF 185 million in Q1, driven by continuing double-digit growth in America

Shareholder Presentation Annual Meeting 2018

2010 First Quarter Results Presentation. 11 th May 2010

SWEDISH MATCH RESULTS PRESENTATION Q3 2017

H. LUNDBECK A/S. Teleconference. 10 August PM CET. Financial results Second quarter 2011

1Q 2014 Earnings Release

Enel Américas 1Q 2018 results

ADM to Acquire Neovia and Probiotics International Limited. July 2, 2018

HILLENBRAND INDUSTRIES INC

World leader in navigated, non-invasive brain stimulation therapy and diagnosis

Value creation through profitable growth Danske Bank Winter Seminar 2017, Copenhagen Lars Rasmussen, President & CEO

1Q 2009 Results Presentation. 12 May 2009

CSL Limited Annual General Meeting 15 October 2015

Slide 1. Investor presentation. London 5 February 2019

Q Investor Kit JANUARY-MARCH 2014

Increase in revenues in line with full-year targets (+1.2%) Very strong growth of Oralair exc. USA (+26%) H revenues and results - 24 July 2014

Not an Offer for Securities

ELICA 2012 Q3 RESULTS. November 14,

Annual Figures 2017/18. Burgdorf, 24 May 2018

Patrick J. Sullivan Chief Executive Officer. January 9, 2018 Investor Presentation

CPH Chemie + Papier Holding AG. Investor Day. Perlen, 13 th September 2018

DISCLOSEABLE AND CONNECTED TRANSACTION AND PROPOSED APPOINTMENT OF CHIEF EXECUTIVE OFFICER

Telekom Austria Group Results for the 1st Quarter May 27, 2003

Hyundai Motor Company 1 st Quarter 2011 Business Results. April 28, 2011

A world leader in allergy immunotherapy

Growth in core businesses offsets weaker non-interest income. DBS Group Holdings 1Q 2005 Financial Results Presentation to Media and Analysts

Summary of Results for the First Half of FY2015/3

Putting ALK on the right growth trajectory

DS-8201 Strategic Collaboration

Korean Airlines Q Results

Advancing Pancreatic & Liver Cancer Treatment

Forward Looking Information

UCB, with a strong year 2017, is reinforcing a solid foundation for investing in future growth

Forward-Looking Statements

Genomic Health. Kim Popovits, Chairman, CEO and President

Q Investor Kit JANUARY-JUNE 2014

Tamsulosin Hydrochloride 0.4 mg Capsule

Q Investor Kit January December 2014

Photocure ASA Executing the Strategy

Second Quarter and First Half 2011 Conference Call. 29 July, SORIN GROUP Presentation 1

Q Investor Kit JANUARY-MARCH 2013

ACACIA PHARMA ANNOUNCES ITS INTENTION TO LAUNCH AN INITIAL GLOBAL OFFERING AND TO LIST ITS SHARES ON EURONEXT BRUSSELS

DELICA D:5 ACTIVE GEAR 0

Corporate Update Simon Hubbert, CEO Bill Kullback, CFO June, 2015

DIEBOLD NIXDORF AG AT GERMANY EQUITY FORUM

Molecular Diagnostic Solutions for Urologic Cancer

METVIX PDT ON THE MARKET IN GERMANY AND UK

JEFFERIES 2016 HEALTHCARE CONFERENCE. June 2016

Walgreen Co. Reports Second Quarter 2010 Earnings Per Diluted Share of 68 Cents; Results Include 2 Cents Per Diluted Share of Restructuring Costs

January 30, 2018 Dow Wilson President and Chief Executive Officer

Leading Intimate Healthcare. Investor presentation Q1 2007/08

SWEDISH MATCH RESULTS PRESENTATION Q4 2018

NOVEL CHECKPOINTS IN IMMUNO-ONCOLOGY KIR NKG2A. C5aR. NKp46 HALF-YEAR RESULTS. Tumor antigen KIR3DL2 CD39 MICA/B CD73 SEPTEMBER 18, 2017

Slide 1. Financial update and closing remarks. Jesper Brandgaard EVP and CFO. RAFAEL DE JESÚS FLORES, Mexico Rafael has haemophilia A

Endesa 1Q 2017 Results 09/05/2017

Company presentation. SEB Nordic Seminar Bella Sky, Copenhagen. Carsten Hellmann, President & CEO 9 January 2018

An exciting combination in a high growth, high margin Nutrition category. Name of chairman

FIRST QUARTER 2018 RESULTS 15 MAY 2018 LUCA BETTONTE, CEO

DelMar Pharmaceuticals Inc. (OTCQX: DMPI, Target Price: $5.75)

Investor presentation. Bioshares Biotech Summit July 2017

For personal use only

For personal use only

TruScreen Annual Meeting

Summary Statement of Financial Position (consolidated)

Photocure ASA Executing the Strategy

Straumann reports 4% growth in local currencies (l.c.) in the first nine months of 2010

FORM8-K HILLENBRAND,INC.

Investor Presentation

MARCH 2014 RESULTS PRESENTATION Madrid, 2014

Presentation to 2019 JP Morgan Healthcare Conference

Developing Xanamem for Alzheimer s Dementia

MDxHealth. Excellent Buy Opportunity. Research Note.

Slide 1. International Operations update. Mike Doustdar EVP International Operations. YASMIN FIEDLER, Germany Yasmin has type 1 diabetes

XXII: CTP Summarizes Scientific Case for Limiting Nicotine in Cigarettes. Company Update October 15, 2018 Industrial & Consumer Technology

MDxHealth. Strong outlook for Research Note.

Investor Presentation June 2012 NASDAQ: CEMI

Mental Toronto Hydro

Universal Biosensors, Inc.

Leading Intimate Healthcare

GI Dynamics, Inc. Q2 16 Quarterly Shareholder Brief 8/11/16

To be the partner of choice Straumann

WntResearch. 100% one-week return? 16 October 2017 PRICE EXPECTATIONS INVESTMENT CASE PRICE TRIGGERS PRICE 12 MONTHS COMPANY PROFILE

1Q 2015 Results A Positive Start to 2015

Bank of America Merrill Lynch HealthCare Conference Bayer HealthCare Dr. Jörg Reinhardt. September 14, 2011

Myriad Genetics Corporate Presentation 06/13/2018

ObsEva Reports Third Quarter 2017 Financial Results and Provides Business Update

About The Report. imarc. Key Questions Answered in this Report:

Transcription:

FIRSTQUARTER2018 RESULTSPRESENTATION May 14 th 2018 Juan Lladó CEO 1

DISCLAIMER This document has been prepared by Técnicas Reunidas S.A. (the Company) solely for use at presentations held in connection with the announcement of the Company's results for the first quarter 2018. This document contains forward-looking statements of the Company and/or its management. These forward looking statements such as statements relating to the Company's or management's intent belief or current expectations of the future growth in the Company's business and capital expenditure in the oil and gas industry in general are subject to risks and variables that are beyond the Company's control and that could materially and adversely affect the outcome and financial effects of the facts expressed implied or projected herein. The Company is under no obligation to update or keep current the information contained in this presentation including any looking forward-statements or to correct any inaccuracies that may later become apparent. No representation or warranty express or implied is made as to and no reliance should be placed on the fairness accuracy completeness or correctness of the information or opinions contained herein. None of the Company or any of its affiliates advisors or representatives shall have any liability whatsoever for any loss arising from any use of this document or its contents or otherwise arising in connection with this document. This document is only provided for information purposes and does not constitute nor may it be interpreted as an offer to sell or exchange or acquire or solicitation for offers to purchase any share in the Company. Any decision to buy or invest in shares in relation to a specific issue must be made on the basis of the information contained in the relevant prospectus filed by the Company in relation to such specific issue. 2

AWARDS RESULTS 1Q 2018 Bn 1Q 2018 Bapco: EPC for the modernization of the Sitra refinery 3.3 4.5 6.7 2.9 4.6 1.1 Other recent jobs FEED for GazpromNeft Refinery of Moscow FEED and feasibility study for Jordan Petroleum Refinery Company for the upgrade and expansion of the Al-Zarqa refinery, in Jordan FEED for a refinery upgrade in South East Asia for an undisclosed client 2013 2014 2015 2016 2017 1Q 2018 3

2018 EXTRAORDINARY PROJECT LAUNCH RESULTS 1Q 2018 Project launch by quarter 5.3 Bnin Six months 2.5 Bnin two years Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 2016 2017 2018 4

BACKLOG RESULTS 1Q 2018 Bn 6.4 8.4 12.1 10.6 9.9 9.7 Backlog replaced: In volume With world-class projects 2013 2014 2015 2016 2017 1Q 2018 5

BACKLOG GEOGRAPHICAL SPLIT RESULTS 1Q 2018 25% 20% 2013 21% 6.4 Bn 34% 10% 13% 2% 1Q 2018 Backlog 9.7Bn Strong presence in most resilient market: Middle East Recurrent customers: a consequence of good execution Key and more complex jobs in each major investment 74% Middle East Europe Latam RoW 6

ACTIVE AND DIVERSIFIED PIPELINE RESULTS 1Q 2018 Strong bidding pipeline, with more diversified opportunities by industries and regions 56% As of 1Q18 44% Middle East RoW 7

FINANCIAL RESULTS RESULTS 1Q 2018 PROFIT AND LOSS Million 1Q 2018 1Q 2017 Var. 2017 Revenues 1,161 1,388-16% 5,068 EBITDA 9.1 60.7-85% 121.9 EBIT Margin 4.1 0.4% 55.5 4.0% -91% 100.4 2.0% Net financial results -4.1-2.8-6.9 Profit before taxes 0.8 51.8-99% 91.2 Taxes -0.2-15.0-27.2 Net profit 0.5 36.8-99% 64.0 Impacts in margins: Lower resources utilisation from delays and cancellations Difficulties on the recovery of extra costs, given this crisis scenario 8

NET CASH POSITION RESULTS 1Q 2018 M 488 413 225 218 231 219 Oil Crisis effects on cash: Peak exposure to the Middle East, with higher needs of working capital Customers cash constraints Lower downpayments TR customers are among the largest and most reliable 2016 1Q2017 2Q 20173Q 2017 2017 1Q 2018 9

DIVIDENDS RESULTS 1Q 2018 TR committed to shareholders remuneration: From the IPO: stated dividend policy of 50% pay out 2006-2017 Average pay out of 59% Difficult crisis scenario: Need to balance shareholders remuneration commitment with strong balance sheet to support growth 10

GUIDANCE AND OUTLOOK RESULTS 1Q 2018 Guidance for 2018: Sales: 4.3 bn - 4.6 bn EBIT margin: 1.5% -2.5%, progressive improvement along 2018 Commitment to shareholder remuneration Slow but solid Almost 4 bnprojects already launched in 2018 and awaiting for another 1,7bn Early engagement in new investments Active, larger and diversified pipeline Outside the Middle East Super- cycle in petrochemicals Stronger franchise after the crisis 11

12